{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:57:17Z","timestamp":1789469837691,"version":"build-2803163510"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"DOI":"10.1007\/s12013-025-01974-1","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T06:20:44Z","timestamp":1765779644000},"page":"1573-1592","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Insight into the Neuroprotective Mechanisms of Resveratrol: Inhibition of Alpha-Synuclein Fibrillation and its Role in Mitigating Toxicity"],"prefix":"10.1007","volume":"84","author":[{"given":"Sepideh Sadat","family":"Seyedfatemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soha","family":"Parsafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir T.","family":"Marvian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamdam","family":"Hourfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhang","family":"Aliakbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najaf","family":"Allahyari Fard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Morshedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"issue":"7","key":"1974_CR1","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.3390\/ijms26072942","volume":"26","author":"KA Jellinger","year":"2025","unstructured":"Jellinger, K. A. (2025). Concomitant pathologies and their impact on Parkinson disease: A narrative overview of current evidence. International Journal of Molecular Sciences, 26(7), 2942.","journal-title":"International Journal of Molecular Sciences"},{"key":"1974_CR2","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.saa.2019.02.004","volume":"214","author":"N. A. Al-Shabib","year":"2019","unstructured":"Al-Shabib, N. A. (2019). A quercetin-based flavanoid (rutin) reverses amyloid fibrillation in \u03b2-lactoglobulin at pH 2.0 and 358 K. Spectrochim Acta A Mol Biomol Spectrosc, 214, 40\u201348.","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"issue":"3","key":"1974_CR3","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","volume":"14","author":"P Calabresi","year":"2023","unstructured":"Calabresi, P., et al. (2023). Alpha-synuclein in parkinson\u2019s disease and other synucleinopathies: From overt neurodegeneration back to early synaptic dysfunction. Cell Death and Disease, 14(3), 176.","journal-title":"Cell Death and Disease"},{"issue":"5","key":"1974_CR4","doi-asserted-by":"publisher","first-page":"p522","DOI":"10.1111\/jnc.14808","volume":"150","author":"P Alam","year":"2019","unstructured":"Alam, P., et al. (2019). \u03b1-synuclein oligomers and fibrils: A spectrum of species, A spectrum of toxicities. Journal of Neurochemistry, 150(5), p522\u2013534.","journal-title":"Journal of Neurochemistry"},{"key":"1974_CR5","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1007\/s00018-008-7589-1","volume":"65","author":"M Parihar","year":"2008","unstructured":"Parihar, M., et al. (2008). Mitochondrial association of alpha-synuclein causes oxidative stress. Cellular and Molecular Life Sciences, 65, 1272\u20131284.","journal-title":"Cellular and Molecular Life Sciences"},{"key":"1974_CR6","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s12035-012-8331-4","volume":"47","author":"MT St\u00f6ckl","year":"2013","unstructured":"St\u00f6ckl, M. T., Zijlstra, N., & Subramaniam, V. (2013). \u03b1-Synuclein oligomers: An amyloid pore? Insights into mechanisms of \u03b1-synuclein oligomer\u2013lipid interactions. Molecular Neurobiology, 47, 613\u2013621.","journal-title":"Molecular Neurobiology"},{"issue":"10","key":"1974_CR7","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1111\/j.1582-4934.2011.01374.x","volume":"15","author":"KM Doyle","year":"2011","unstructured":"Doyle, K. M., et al. (2011). Unfolded proteins and Endoplasmic reticulum stress in neurodegenerative disorders. Journal of Cellular and Molecular Medicine, 15(10), 2025\u20132039.","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"4","key":"1974_CR8","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrm2873","volume":"11","author":"P Brundin","year":"2010","unstructured":"Brundin, P., Melki, R., & Kopito, R. (2010). Prion-like transmission of protein aggregates in neurodegenerative diseases. Nature Reviews Molecular Cell Biology, 11(4), 301\u2013307.","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"1974_CR9","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.ijbiomac.2022.03.092","volume":"209","author":"S Parsafar","year":"2022","unstructured":"Parsafar, S., et al. (2022). Insights into the inhibitory mechanism of skullcapflavone II against \u03b1-synuclein aggregation and its mediated cytotoxicity. International Journal of Biological Macromolecules, 209, 426\u2013440.","journal-title":"International Journal of Biological Macromolecules"},{"issue":"8","key":"1974_CR10","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1111\/jnc.15907","volume":"168","author":"T Srivastava","year":"2024","unstructured":"Srivastava, T., et al. (2024). A natural small molecule-mediated Inhibition of alpha\u2010synuclein aggregation leads to neuroprotection in caenorhabditis elegans. Journal of Neurochemistry, 168(8), 1640\u20131654.","journal-title":"Journal of Neurochemistry"},{"issue":"10","key":"1974_CR11","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.3390\/molecules25102444","volume":"25","author":"K Ono","year":"2020","unstructured":"Ono, K., et al. (2020). Anti-aggregation effects of phenolic compounds on \u03b1-synuclein. Molecules, 25(10), 2444.","journal-title":"Molecules"},{"key":"1974_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1326-3-19","volume":"3","author":"J Lewis","year":"2008","unstructured":"Lewis, J., et al. (2008). In vivo Silencing of alpha-synuclein using naked SiRNA. Mol Neurodegener, 3, 1\u201310.","journal-title":"Mol Neurodegener"},{"issue":"7","key":"1974_CR13","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1172\/JCI64502","volume":"125","author":"AD Zharikov","year":"2015","unstructured":"Zharikov, A. D., et al. (2015). ShRNA targeting \u03b1-synuclein prevents neurodegeneration in a parkinson\u2019s disease model. The Journal of Clinical Investigation, 125(7), 2721\u20132735.","journal-title":"The Journal of Clinical Investigation"},{"issue":"28","key":"1974_CR14","doi-asserted-by":"publisher","first-page":"9441","DOI":"10.1523\/JNEUROSCI.5314-13.2014","volume":"34","author":"D Games","year":"2014","unstructured":"Games, D., et al. (2014). Reducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in parkinson\u2019s disease-like models. Journal of Neuroscience, 34(28), 9441\u20139454.","journal-title":"Journal of Neuroscience"},{"key":"1974_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-017-0154-3","volume":"12","author":"TE Moors","year":"2017","unstructured":"Moors, T. E., et al. (2017). Therapeutic potential of autophagy-enhancing agents in parkinson\u2019s disease. Mol Neurodegener, 12, 1\u201318.","journal-title":"Mol Neurodegener"},{"issue":"46","key":"1974_CR16","doi-asserted-by":"publisher","first-page":"19627","DOI":"10.1039\/C5NR05663B","volume":"7","author":"H Mohammad-Beigi","year":"2015","unstructured":"Mohammad-Beigi, H., et al. (2015). Strong interactions with polyethylenimine-coated human serum albumin nanoparticles (PEI-HSA NPs) alter \u03b1-synuclein conformation and aggregation kinetics. Nanoscale, 7(46), 19627\u201319640.","journal-title":"Nanoscale"},{"issue":"19","key":"1974_CR17","doi-asserted-by":"publisher","first-page":"9174","DOI":"10.1039\/C8NR00632F","volume":"10","author":"F Aliakbari","year":"2018","unstructured":"Aliakbari, F., et al. (2018). The potential of zwitterionic nanoliposomes against neurotoxic alpha-synuclein aggregates in parkinson\u2019s disease. Nanoscale, 10(19), 9174\u20139185.","journal-title":"Nanoscale"},{"key":"1974_CR18","doi-asserted-by":"publisher","first-page":"e46775","DOI":"10.7554\/eLife.46775","volume":"9","author":"S Sangwan","year":"2020","unstructured":"Sangwan, S., et al. (2020). Inhibition of synucleinopathic seeding by rationally designed inhibitors. Elife, 9, e46775.","journal-title":"Elife"},{"issue":"7","key":"1974_CR19","doi-asserted-by":"publisher","first-page":"2007765","DOI":"10.1002\/adfm.202007765","volume":"31","author":"F Aliakbari","year":"2021","unstructured":"Aliakbari, F., et al. (2021). Multiple protective roles of Nanoliposome-Incorporated Baicalein against Alpha\u2010Synuclein aggregates. Advanced Functional Materials, 31(7), 2007765.","journal-title":"Advanced Functional Materials"},{"issue":"53","key":"1974_CR20","doi-asserted-by":"publisher","first-page":"6717","DOI":"10.1039\/D4CC00822G","volume":"60","author":"S Sharma","year":"2024","unstructured":"Sharma, S., & Deep, S. (2024). Inhibition of fibril formation by polyphenols: Molecular mechanisms, challenges, and prospective solutions. Chemical Communications, 60(53), 6717\u20136727.","journal-title":"Chemical Communications"},{"issue":"8","key":"1974_CR21","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1002\/fsn3.855","volume":"6","author":"M Koushki","year":"2018","unstructured":"Koushki, M., et al. (2018). Resveratrol: A miraculous natural compound for diseases treatment. Food Science & Nutrition, 6(8), 2473\u20132490.","journal-title":"Food Science & Nutrition"},{"issue":"3","key":"1974_CR22","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3390\/foods9030340","volume":"9","author":"X Meng","year":"2020","unstructured":"Meng, X., et al. (2020). Health benefits and molecular mechanisms of resveratrol: A narrative review. Foods, 9(3), 340.","journal-title":"Foods"},{"key":"1974_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11357-015-9777-x","volume":"37","author":"F Sarubbo","year":"2015","unstructured":"Sarubbo, F., et al. (2015). Improving effect of chronic Resveratrol treatment on central monoamine synthesis and cognition in aged rats. Age, 37, 1\u201311.","journal-title":"Age"},{"issue":"3","key":"1974_CR24","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2174\/1570159X17666181127125704","volume":"17","author":"I Carrera","year":"2019","unstructured":"Carrera, I., & Cacabelos, R. (2019). Current drugs and potential future neuroprotective compounds for parkinson\u2019s disease. Current Neuropharmacology, 17(3), 295\u2013306.","journal-title":"Current Neuropharmacology"},{"key":"1974_CR25","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3389\/fnagi.2020.00103","volume":"12","author":"BD Arbo","year":"2020","unstructured":"Arbo, B. D., et al. (2020). Resveratrol derivatives as potential treatments for alzheimer\u2019s and parkinson\u2019s disease. Frontiers in Aging Neuroscience, 12, 103.","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"12","key":"1974_CR26","doi-asserted-by":"publisher","first-page":"6414","DOI":"10.1039\/C8FO00964C","volume":"9","author":"L Zhang","year":"2018","unstructured":"Zhang, L., et al. (2018). Resveratrol alleviates motor and cognitive deficits and neuropathology in the A53T \u03b1-synuclein mouse model of parkinson\u2019s disease. Food & Function, 9(12), 6414\u20136426.","journal-title":"Food & Function"},{"key":"1974_CR27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.bbrc.2021.08.049","volume":"574","author":"E Chau","year":"2021","unstructured":"Chau, E., et al. (2021). Inhibition of alpha-synuclein aggregation by AM17, a synthetic Resveratrol derivative. Biochemical and Biophysical Research Communications, 574, 85\u201390.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"3","key":"1974_CR28","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1021\/acschemneuro.3c00571","volume":"15","author":"E Illes-Toth","year":"2024","unstructured":"Illes-Toth, E., Rempel, D. L., & Gross, M. L. (2024). Exploration of Resveratrol as a potent modulator of \u03b1-Synuclein fibril formation. Acs Chemical Neuroscience, 15(3), 503\u2013516.","journal-title":"Acs Chemical Neuroscience"},{"issue":"1","key":"1974_CR29","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.pep.2005.02.014","volume":"42","author":"C Huang","year":"2005","unstructured":"Huang, C., et al. (2005). A new method for purification of Recombinant human \u03b1-synuclein in Escherichia coli. Protein Expression Purif, 42(1), 173\u2013177.","journal-title":"Protein Expression Purif"},{"key":"1974_CR30","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.ijbiomac.2020.03.238","volume":"155","author":"AT Marvian","year":"2020","unstructured":"Marvian, A. T., et al. (2020). The status of the terminal regions of \u03b1-synuclein in different forms of aggregates during fibrillization. International Journal of Biological Macromolecules, 155, 543\u2013550.","journal-title":"International Journal of Biological Macromolecules"},{"issue":"11","key":"1974_CR31","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1074\/jbc.RA118.005723","volume":"294","author":"H Mohammad-Beigi","year":"2019","unstructured":"Mohammad-Beigi, H., et al. (2019). Oleuropein derivatives from Olive fruit extracts reduce \u03b1-synuclein fibrillation and oligomer toxicity. Journal of Biological Chemistry, 294(11), 4215\u20134232.","journal-title":"Journal of Biological Chemistry"},{"issue":"9","key":"1974_CR32","doi-asserted-by":"publisher","first-page":"e0184483","DOI":"10.1371\/journal.pone.0184483","volume":"12","author":"M Sashourpour","year":"2017","unstructured":"Sashourpour, M., et al. (2017). A study on the modulation of alpha-synuclein fibrillation by scutellaria pinnatifida extracts and its neuroprotective properties. PLoS One, 12(9), e0184483.","journal-title":"PLoS One"},{"issue":"5","key":"1974_CR33","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nsmb.3194","volume":"23","author":"MD Tuttle","year":"2016","unstructured":"Tuttle, M. D., et al. (2016). Solid-state NMR structure of a pathogenic fibril of full-length human \u03b1-synuclein. Nature Structural & Molecular Biology, 23(5), 409\u2013415.","journal-title":"Nature Structural & Molecular Biology"},{"issue":"1","key":"1974_CR34","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1039\/C9CP04610K","volume":"22","author":"Y Zou","year":"2020","unstructured":"Zou, Y., et al. (2020). Critical nucleus of Greek-key-like core of \u03b1-synuclein protofibril and its disruption by dopamine and norepinephrine. Physical Chemistry Chemical Physics: Pccp, 22(1), 203\u2013211.","journal-title":"Physical Chemistry Chemical Physics: Pccp"},{"key":"1974_CR35","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ejpb.2015.04.002","volume":"93","author":"\u0160 Zupan\u010di\u010d","year":"2015","unstructured":"Zupan\u010di\u010d, \u0160., Lavri\u010d, Z., & Kristl, J. (2015). Stability and solubility of trans-resveratrol are strongly influenced by pH and temperature. European Journal of Pharmaceutics and Biopharmaceutics, 93, 196\u2013204.","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"issue":"6","key":"1974_CR36","doi-asserted-by":"publisher","first-page":"5191","DOI":"10.3390\/ijms24065191","volume":"24","author":"T P\u00e1lmad\u00f3ttir","year":"2023","unstructured":"P\u00e1lmad\u00f3ttir, T., et al. (2023). Morphology-dependent interactions between \u03b1-synuclein monomers and fibrils. International Journal of Molecular Sciences, 24(6), 5191.","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"1974_CR37","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/bip.360360310","volume":"36","author":"ME Holtzer","year":"1995","unstructured":"Holtzer, M. E., & Holtzer, A. (1995). The use of spectral decomposition via the convex constraint algorithm in interpreting the CD-observed unfolding transitions of C coils. Biopolymers: Original Research on Biomolecules, 36(3), 365\u2013379.","journal-title":"Biopolymers: Original Research on Biomolecules"},{"issue":"1","key":"1974_CR38","doi-asserted-by":"publisher","first-page":"12175","DOI":"10.1038\/s41598-020-68887-2","volume":"10","author":"A Khammari","year":"2020","unstructured":"Khammari, A., Arab, S. S., & Ejtehadi, M. R. (2020). The hot sites of \u03b1-synuclein in amyloid fibril formation. Scientific Reports, 10(1), 12175.","journal-title":"Scientific Reports"},{"issue":"11","key":"1974_CR39","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.3390\/cells11111732","volume":"11","author":"M Vidovi\u0107","year":"2022","unstructured":"Vidovi\u0107, M., & Rikalovic, M. G. (2022). Alpha-synuclein aggregation pathway in parkinson\u2019s disease: Current status and novel therapeutic approaches. Cells, 11(11), 1732.","journal-title":"Cells"},{"issue":"31","key":"1974_CR40","doi-asserted-by":"publisher","first-page":"24228","DOI":"10.1074\/jbc.M110.133108","volume":"285","author":"ARA Ladiwala","year":"2010","unstructured":"Ladiwala, A. R. A., et al. (2010). Resveratrol selectively remodels soluble oligomers and fibrils of amyloid A\u03b2 into off-pathway conformers. Journal of Biological Chemistry, 285(31), 24228\u201324237.","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"1974_CR41","first-page":"5538200","volume":"2021","author":"S Li","year":"2021","unstructured":"Li, S., et al. (2021). Research progress on natural product ingredients\u2019 therapeutic effects on parkinson\u2019s disease by regulating autophagy. Evidence-Based Complementary and Alternative Medicine, 2021(1), 5538200.","journal-title":"Evidence-Based Complementary and Alternative Medicine"},{"key":"1974_CR42","doi-asserted-by":"publisher","first-page":"104012","DOI":"10.1016\/j.bioorg.2020.104012","volume":"101","author":"S Deike","year":"2020","unstructured":"Deike, S., et al. (2020). \u03b2-Turn mimetic synthetic peptides as amyloid-\u03b2 aggregation inhibitors. Bioorganic Chemistry, 101, 104012.","journal-title":"Bioorganic Chemistry"},{"issue":"2\u20133","key":"1974_CR43","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jmb.2012.01.055","volume":"421","author":"TM Doran","year":"2012","unstructured":"Doran, T. M., et al. (2012). Turn nucleation perturbs amyloid \u03b2 self-assembly and cytotoxicity. Journal of Molecular Biology, 421(2\u20133), 315\u2013328.","journal-title":"Journal of Molecular Biology"},{"issue":"6","key":"1974_CR44","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.bpj.2011.02.010","volume":"100","author":"P Jiang","year":"2011","unstructured":"Jiang, P., et al. (2011). Resveratrol inhibits the formation of multiple-layered \u03b2-sheet oligomers of the human islet amyloid polypeptide segment 22\u201327. Biophys J, 100(6), 1550\u20131558.","journal-title":"Biophys J"},{"key":"1974_CR45","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/bs.ircmb.2016.08.010","volume":"329","author":"N Cremades","year":"2017","unstructured":"Cremades, N., Chen, S., & Dobson, C. (2017). Structural characteristics of \u03b1-synuclein oligomers. Int Rev Cell Mol Biol, 329, 79\u2013143.","journal-title":"Int Rev Cell Mol Biol"},{"key":"1974_CR46","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ejmech.2019.01.045","volume":"167","author":"V Oliveri","year":"2019","unstructured":"Oliveri, V. (2019). Toward the discovery and development of effective modulators of \u03b1-synuclein amyloid aggregation. European Journal of Medicinal Chemistry, 167, 10\u201336.","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"1","key":"1974_CR47","doi-asserted-by":"publisher","first-page":"11469","DOI":"10.1038\/s41598-017-11664-5","volume":"7","author":"M H\u00f6llerhage","year":"2017","unstructured":"H\u00f6llerhage, M., et al. (2017). Protective efficacy of phosphodiesterase-1 Inhibition against alpha-synuclein toxicity revealed by compound screening in LUHMES cells. Scientific Reports, 7(1), 11469.","journal-title":"Scientific Reports"},{"issue":"19","key":"1974_CR48","doi-asserted-by":"publisher","first-page":"6085","DOI":"10.1021\/bi0600749","volume":"45","author":"M Masuda","year":"2006","unstructured":"Masuda, M., et al. (2006). Small molecule inhibitors of \u03b1-synuclein filament assembly. Biochemistry, 45(19), 6085\u20136094.","journal-title":"Biochemistry"},{"issue":"1","key":"1974_CR49","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/prot.24332","volume":"82","author":"C. L. Pham","year":"2014","unstructured":"Pham, C. L. (2014). Guanidine hydrochloride denaturation of dopamine-induced \u03b1\u2010synuclein oligomers: A small\u2010angle X\u2010ray scattering study. Proteins, 82(1), 10\u201321.","journal-title":"Proteins"},{"issue":"4","key":"1974_CR50","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.molmed.2020.01.005","volume":"26","author":"J Pujols","year":"2020","unstructured":"Pujols, J., et al. (2020). Chemical chaperones as novel drugs for parkinson\u2019s disease. Trends in Molecular Medicine, 26(4), 408\u2013421.","journal-title":"Trends in Molecular Medicine"},{"issue":"1","key":"1974_CR51","doi-asserted-by":"publisher","first-page":"9228","DOI":"10.1038\/srep09228","volume":"5","author":"D Ghosh","year":"2015","unstructured":"Ghosh, D., et al. (2015). Structure based aggregation studies reveal the presence of helix-rich intermediate during \u03b1-Synuclein aggregation. Scientific Reports, 5(1), 9228.","journal-title":"Scientific Reports"},{"issue":"63","key":"1974_CR52","doi-asserted-by":"publisher","first-page":"8667","DOI":"10.1039\/C8CC02204F","volume":"54","author":"M T\u00f6rnquist","year":"2018","unstructured":"T\u00f6rnquist, M., et al. (2018). Secondary nucleation in amyloid formation. Chemical Communications, 54(63), 8667\u20138684.","journal-title":"Chemical Communications"},{"key":"1974_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13041-017-0340-9","volume":"10","author":"L Puspita","year":"2017","unstructured":"Puspita, L., Chung, S. Y., & Shim, J. (2017). Oxidative stress and cellular pathologies in parkinson\u2019s disease. Molecular Brain, 10, 1\u201312.","journal-title":"Molecular Brain"},{"issue":"1","key":"1974_CR54","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41531-023-00583-0","volume":"9","author":"N Ito","year":"2023","unstructured":"Ito, N., et al. (2023). Extracellular high molecular weight \u03b1-synuclein oligomers induce cell death by disrupting the plasma membrane. Npj Parkinson\u2019s Disease, 9(1), 139.","journal-title":"Npj Parkinson\u2019s Disease"},{"issue":"4","key":"1974_CR55","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1128\/IAI.73.4.1907-1916.2005","volume":"73","author":"SL Fink","year":"2005","unstructured":"Fink, S. L., & Cookson, B. T. (2005). Apoptosis, pyroptosis, and necrosis: Mechanistic description of dead and dying eukaryotic cells. Infection and Immunity, 73(4), 1907\u20131916.","journal-title":"Infection and Immunity"},{"issue":"3","key":"1974_CR56","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1021\/acschemneuro.6b00287","volume":"8","author":"A Sidhu","year":"2017","unstructured":"Sidhu, A., et al. (2017). Distinct mechanisms determine \u03b1-synuclein fibril morphology during growth and maturation. Acs Chemical Neuroscience, 8(3), 538\u2013547.","journal-title":"Acs Chemical Neuroscience"},{"issue":"10","key":"1974_CR57","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1021\/acschemneuro.3c00162","volume":"14","author":"G Martins","year":"2023","unstructured":"Martins, G., Nascimento, C., & Galamba, N. (2023). Mechanistic insights into polyphenols\u2019 aggregation Inhibition of \u03b1-synuclein and related peptides. Acs Chemical Neuroscience, 14(10), 1905\u20131920.","journal-title":"Acs Chemical Neuroscience"},{"issue":"1","key":"1974_CR58","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1038\/s41467-018-05971-2","volume":"9","author":"B Li","year":"2018","unstructured":"Li, B., et al. (2018). Cryo-EM of full-length \u03b1-synuclein reveals fibril polymorphs with a common structural kernel. Nature Communications, 9(1), 3609.","journal-title":"Nature Communications"},{"issue":"1","key":"1974_CR59","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1471-4159.2006.03707.x","volume":"97","author":"K Ono","year":"2006","unstructured":"Ono, K., & Yamada, M. (2006). Antioxidant compounds have potent anti-fibrillogenic and fibril\u2010destabilizing effects for \u03b1\u2010synuclein fibrils in vitro. Journal of Neurochemistry, 97(1), 105\u2013115.","journal-title":"Journal of Neurochemistry"},{"issue":"1","key":"1974_CR60","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1747-0285.2005.00318.x","volume":"67","author":"Y Porat","year":"2006","unstructured":"Porat, Y., Abramowitz, A., & Gazit, E. (2006). Inhibition of amyloid fibril formation by polyphenols: Structural similarity and aromatic interactions as a common Inhibition mechanism. Chemical Biology & Drug Design, 67(1), 27\u201337.","journal-title":"Chemical Biology & Drug Design"},{"key":"1974_CR61","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cplett.2018.12.042","volume":"717","author":"E Srinivasan","year":"2019","unstructured":"Srinivasan, E., & Rajasekaran, R. (2019). Effect of \u03b2-cyclodextrin-EGCG complexion against aggregated a-synuclein through density functional theory and discrete molecular dynamics. Chemical Physics Letters, 717, 38\u201346.","journal-title":"Chemical Physics Letters"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-025-01974-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-025-01974-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-025-01974-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T06:01:35Z","timestamp":1772863295000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-025-01974-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["1974"],"URL":"https:\/\/doi.org\/10.1007\/s12013-025-01974-1","relation":{},"ISSN":["1559-0283"],"issn-type":[{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"assertion":[{"value":"4 December 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Confilict of Interests"}}]}}